BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 37974196)

  • 21. A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer's Disease.
    Huang X
    Cells; 2023 May; 12(10):. PubMed ID: 37408203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perish in the Attempt: Regulated Cell Death in Regenerative and Nonregenerative Tissue.
    Li S; Tao G
    Antioxid Redox Signal; 2023 Dec; 39(16-18):1053-1069. PubMed ID: 37218435
    [No Abstract]   [Full Text] [Related]  

  • 23. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis.
    Nie D; Chen C; Li Y; Zeng C
    Blood Sci; 2022 Jul; 4(3):152-154. PubMed ID: 36518588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulated cell death in cancer: from pathogenesis to treatment.
    Gong L; Huang D; Shi Y; Liang Z; Bu H
    Chin Med J (Engl); 2023 Mar; 136(6):653-665. PubMed ID: 35950752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
    Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
    Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting ferroptosis in cardio-metabolic-diseases: Mechanisms and therapeutic prospects.
    Zhang JB; Tong J; Sun DY; Fu JT; Li DJ; Wang P
    Med Res Rev; 2023 May; 43(3):683-712. PubMed ID: 36658745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma biology and treatment: a review of novel regulated cell death-based approaches.
    Hsieh MY; Hsu SK; Liu TY; Wu CY; Chiu CC
    Cancer Cell Int; 2024 Feb; 24(1):63. PubMed ID: 38336727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Organic Photosensitizer Designs for Evoking Proinflammatory Regulated Cell Death in Antitumor Immunotherapy.
    Sun X; Li M; Wang P; Bai Q; Cao X; Mao D
    Small Methods; 2023 May; 7(5):e2201614. PubMed ID: 36960933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine-mediated regulated cell death in cancer immunotherapy.
    Sun Y; Lian T; Huang Q; Chang Y; Li Y; Guo X; Kong W; Yang Y; Zhang K; Wang P; Wang X
    J Control Release; 2023 Dec; 364():174-194. PubMed ID: 37871752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micronutrients/miRs/ATP networking in mitochondria: Clinical intervention with ferroptosis, cuproptosis, and calcium burden.
    Prasad Panda S; Kesharwani A
    Mitochondrion; 2023 Jul; 71():1-16. PubMed ID: 37172668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulated cell death pathways in cardiomyopathy.
    Sheng SY; Li JM; Hu XY; Wang Y
    Acta Pharmacol Sin; 2023 Aug; 44(8):1521-1535. PubMed ID: 36914852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metal-Based Photosensitizers as Inducers of Regulated Cell Death Mechanisms.
    Zhang Y; Doan BT; Gasser G
    Chem Rev; 2023 Aug; 123(16):10135-10155. PubMed ID: 37534710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulated cell death (RCD) in cancer: key pathways and targeted therapies.
    Peng F; Liao M; Qin R; Zhu S; Peng C; Fu L; Chen Y; Han B
    Signal Transduct Target Ther; 2022 Aug; 7(1):286. PubMed ID: 35963853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases.
    You H; Wang L; Bu F; Meng H; Huang C; Fang G; Li J
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis.
    Li J; Liu J; Li J; Feng A; Nie Y; Yang Z; Zhang W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11647-11659. PubMed ID: 37405477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNAs and regulated cell death in tumor cells.
    Wu Y; Wen X; Xia Y; Yu X; Lou Y
    Front Oncol; 2023; 13():1170336. PubMed ID: 37313458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.
    Qin R; You FM; Zhao Q; Xie X; Peng C; Zhan G; Han B
    J Hematol Oncol; 2022 Sep; 15(1):133. PubMed ID: 36104717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
    Ryter SW
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.